Introduction
The South African Medical Research Council (SAMRC) is a national public research organization dedicated to improving health and quality of life through medical research, innovation, capacity development and technology transfer. It conducts and funds laboratory investigations, clinical studies, public health research and the development of health technologies.
The SAMRC is one of South Africa’s most important sources of medical research funding. Its work addresses the country’s major health challenges, including HIV/AIDS, tuberculosis, maternal and child health conditions, non-communicable diseases and interpersonal violence.
By generating scientific evidence and supporting health researchers, the council helps inform public policy, improve clinical practice and develop locally relevant diagnostics, medicines, vaccines and medical technologies.
History and Background
The South African Medical Research Council was established in 1969 to strengthen health research and improve the health of South Africa’s population. Its legal mandate is governed by the South African Medical Research Council Act 58 of 1991.
The council was created to conduct research, coordinate medical research activities and facilitate the practical application of scientific discoveries. Its responsibilities have expanded over time to include research grant management, postgraduate capacity development, innovation funding, intellectual property support and the commercialization of health technologies.
SAMRC research encompasses laboratory science, epidemiology, clinical research, population health, health systems and public health policy. The organization has developed partnerships with South African universities, government departments, science councils, international research agencies, philanthropic funders and private-sector organizations.
Mission and Purpose
The SAMRC’s vision is to build a healthy nation through research, innovation and transformation.
Its mission is to advance health and quality of life, address health inequities and strengthen South Africa’s research system by conducting and funding relevant health research. The council also supports innovation, capacity development and the translation of research findings into policies, services and medical products.
Its mandate centers on South Africa’s quadruple burden of disease. This includes maternal, newborn and child health conditions; HIV/AIDS and tuberculosis; non-communicable diseases; and interpersonal violence.
The SAMRC seeks to generate reliable evidence that government agencies and healthcare providers can use to design policies, allocate resources and improve health services. It also promotes transformation by supporting emerging researchers, historically disadvantaged institutions and scientists from underrepresented groups.
Governance and Structure
The SAMRC is classified as a Schedule 3A public entity under South African law. It reports to the National Minister of Health and is accountable to Parliament for its performance and use of public resources.
Its governance is guided by the SAMRC Act, the Public Finance Management Act and South Africa’s principles of public-sector corporate governance. The Minister of Health appoints the SAMRC Board, which serves as the organization’s accounting authority.
The Board provides strategic direction, approves policies and oversees financial and institutional performance. It also appoints the SAMRC President, who is responsible for implementing the Board’s mandate and managing the organization’s operations.
The council operates through intramural research units located within the SAMRC and extramural units hosted by universities and other recognized institutions. This model enables it to combine internal expertise with research capacity distributed across South Africa.
Funding and Grants
The SAMRC receives baseline public funding through the South African government, particularly the National Department of Health. It also mobilizes resources through partnerships with other government departments, international research agencies, philanthropic foundations and health innovation organizations.
These resources support research conducted within the council and grants awarded to external institutions and researchers. Opportunities are normally advertised through competitive Requests for Applications, with each call establishing its own thematic priorities, eligibility requirements, budget, duration and application process.
The Self-Initiated Research Grants Programme supports original health research developed by researchers at recognized institutions. In its 2025 call, grants were available for up to R200,000 per year for a maximum of three years. Applications were accepted from early-career researchers and more established researchers able to demonstrate a strong capacity-building component.
The Extramural Research Unit model provides longer-term support for major research programs. Funding is approved in five-year cycles and may continue for up to 15 years, depending on performance. Host institutions are expected to provide co-funding and attract additional external resources.
Other SAMRC funding mechanisms include postgraduate scholarships, technology development grants, health innovation calls, international collaborative research programs and targeted funding for diseases or public health priorities.
Applicants must review each opportunity separately because eligibility varies. Some calls are open to South African universities, science councils and nonprofit research organizations, while others are limited to SAMRC researchers, staff or students. Current and previous opportunities are published through the council’s funding portal.
Major Programs and Initiatives
The SAMRC manages multiple programs covering biomedical discovery, clinical research, population health, research capacity and technology commercialization.
The Strategic Health Innovation Partnerships programme is a collaboration between the SAMRC and the Department of Science, Technology and Innovation. It funds multidisciplinary and multi-institutional projects developing new drugs, vaccines, diagnostics, treatments, medical devices and prevention strategies.
SHIP supports work related to HIV, tuberculosis, malaria, antimicrobial resistance, non-communicable diseases, precision medicine, maternal and child health and other national priorities. Projects are commonly selected through competitive calls and rigorous peer review. The program also helps move promising discoveries from laboratories toward clinical validation and practical use.
Grand Challenges South Africa supports high-risk and potentially transformative scientific ideas addressing major health and development problems. Established in 2013, it operates as part of the international Grand Challenges network and works with government and philanthropic partners.
The SAMRC–Technology Innovation Agency Seed Fund supports health technologies at different stages of development. Depending on the call, funding may help researchers establish proof of concept, build prototypes, assess markets, meet regulatory requirements or develop minimum viable products.
The council also operates intramural research units addressing subjects such as burden of disease, gender and health, HIV prevention, tuberculosis, alcohol and drug use, biomedical research and health systems. Its Burden of Disease Research Unit collects and analyzes mortality, disease and population-health information used for national planning.
In April 2026, the SAMRC established seven additional Extramural Research Units, bringing the total number of such units to 30. These units connect scientists at universities and research organizations with long-term funding for priority health research.
Impact and Examples of Work Funded
SAMRC-supported research has strengthened South Africa’s ability to understand disease patterns, develop medical interventions and respond to public health challenges.
Its disease surveillance and burden-of-disease research provide evidence on mortality, population health and major risk factors. Government departments and health planners can use these findings to identify priorities, evaluate interventions and allocate healthcare resources.
Through SHIP, the council has supported research into HIV prevention, vaccines, diagnostics and treatments. A 2025 HIV Research and Innovation call made approximately R60 million available for collaborative projects developing improved prevention, testing and therapeutic options. The call also emphasized local manufacturing to reduce dependence on imported health products.
The council has invested in tuberculosis research and research-capacity development at historically disadvantaged institutions, including the universities of Venda and Limpopo. These investments help broaden participation in South Africa’s medical research system while advancing new approaches to a disease that remains a major national health concern.
In 2026, Grand Challenges South Africa committed R6 million to two early-stage drug-discovery platforms under the African Drug Discovery Accelerator. The initiative supports African-led translational research and strengthens women’s leadership in drug discovery.
The SAMRC is also contributing to the development of the South African 110K Human Genome Program. Announced through a partnership with the Department of Science, Technology and Innovation and Illumina, the initiative aims to sequence 110,000 human genomes and establish a comprehensive national genomic reference database. Its initial phase will cover 10,000 genomes and help develop the National Genome Archive.
Other funding has supported cancer research, antimicrobial resistance, mpox studies, maternal and newborn health, artificial intelligence for healthcare, women’s sexual and reproductive health, and affordable diagnostic technologies.
These investments demonstrate the SAMRC’s role across the health research pathway—from basic and applied research to product development, clinical evaluation, evidence translation and commercialization.
Conclusion
The South African Medical Research Council is a central institution in South Africa’s health research and innovation system. Since its establishment in 1969, it has supported scientific discovery, public health research, medical technology development and evidence-based health policy.
Its funding portfolio includes self-initiated research grants, long-term research units, postgraduate scholarships, strategic health innovation programs and international partnerships. These mechanisms support established scientists while building opportunities for early-career researchers and historically disadvantaged institutions.
For researchers, universities, science councils and nonprofit research organizations, the SAMRC offers important opportunities to secure medical research grants and participate in collaborative health initiatives. Eligibility, funding amounts and application procedures vary by call, making it essential to review the official guidelines carefully.
For more information, visit here.
